Activity of KRM-1648, a New Benzoxazinorifamycin, Against Mycobacterium Tuberculosis in a Murine Model.
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.38.10.2245
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 1994
Authors
Publisher
American Society for Microbiology